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ABSTRACT 22
It has long been known that Tissue Factor (TF) plays a role in blood coagulation and has a direct 23 thrombotic action that is closely related to cardiovascular risk, but it is becoming increasingly 24
clear that it has a much wider range of biological functions that range from inflammation to 25 immunity. It is also involved in maintaining heart hemostasis and structure, and the observation 26 that it is down-regulated in the myocardium of patients with dilated cardiomyopathy suggests that 27 it influences cell-to-cell contact stability and contractility, and thus contributes to cardiac 28 dysfunction. However, the molecular mechanisms underlying these coagulation-independent 29 functions have not yet been fully elucidated. 30 In order to analyse the influence of TF on the cardiomyocitic proteome, we used functional 31 biochemical approaches incorporating label-free quantitative proteomics and gene silencing, and 32
found that this provided a powerful means of identifying a new role for TF in regulating splicing 33 machinery together with the expression of several proteins of the spliceosome, and mRNA 34 metabolism with a considerable impact on cell viability. 35 
36

SIGNIFICANCE 37
In this study, using quantitative proteomics and functional biochemical approaches, we define for 38 the first time that, in addition to its primary role in blood coagulation, Tissue Factor also plays a 39 novel role in regulating cell splicing machinery, with a relevant impact on cell survival. 40 This new function may help to explain the wide range of biological activities of TF, and thus 41 provide fruitful clues for developing new strategies for treating human diseases in which TF is 42 dysregulated. 43 
44
INTRODUCTION 45
Tissue factor (TF), a 47-kDa transmembrane cell-surface protein, is primarily known as the 46 initiator of the coagulation cascade [1, 2] but it also has a wide variety of coagulation-47 independent functions: it is required for embryonic blood vessel formation [3] , plays a role in 48 tumour metastasis [4] , and is involved in the maintenance of heart hemostasis and structure [5] . 49 Fibroblasts and cardiomyocytes of the heart constitutively express high levels of TF, which is 50 located in the sarcolemma of cardiomyocytes and the intercalated discs of myocardium, where it 51 co-localises with cytoskeletal and adhesion proteins such as desmin and vinculin [6] . 52 Furthermore, actin-binding protein 280 has been identified as a ligand for the TF cytoplasmic 53 domain by two-hybrid screening [7] . These findings of co-localisation and interactions with 54 structural cardiac proteins has led to the hypothesis that TF may also play a non-hemostatic role 55 in the heart by maintaining the structural integrity and function of cardiac muscle [6, 7] . 56 Furthermore, the pattern of TF expression in cardiomyocytes during human and murine heart 57 development indicates that TF may act as a morphogenic factor in the developing heart [8] . 58 TF is down-regulated in the myocardium of patients with dilated cardiomyopathy (DCM). 59 Myocardial specimens from DCM hearts show that it has an altered cell localisation, being 60 redistributed from the Z-bands to the perinuclear cytosol [9] . This further suggests that decreased 61 TF expression and change in localisation may affect contractility and cell-to-cell contact stability, 62 thus contributing to cardiac dysfunction in patients with DCM [9] . 63 The in vitro and in vivo administration of lipopolysaccharide reduces TF mRNA and protein 64 expression in cardiomyocytes, but not in lung, kidney or brain [6, 10, 11] , which not only clearly 65 demonstrates that TF is uniquely regulated in the heart, but also suggests that it has potentially 66 unique functions in heart morphogenesis and the maintenance of cardiac muscle structure. 67
Immunofluorescence analysis 116
The cells were fixed with 2% w/v paraformaldehyde containing 0.2% v/v Triton X-100 for 10 117 min at room temperature and, after washing with PBS, were treated with acetone at -20°C for 5 118 min, and rinsed three times with PBS. The samples were first incubated with the anti-SRSF2 119 antibody (Sigma-Aldrich, Milan, Italy), and then with the Alexa Fluor 488 goat anti-mouse IgG 120 antibody (Molecular Probes, Life Technologies Italia, Monza, Italy); the nuclei were stained with 121 DAPI (Sigma-Aldrich, Milan, Italy). The images were acquired using an LSM710 Zeiss confocal 122 inverted microscope equipped with Ar/Kr and UV lasers, and Zeiss Zen 2008 software. 123
124
In situ hybridisation 125
The cells were prepared for fluorescence in situ hybridisation by means of fixation with 4% w/v 126 paraformaldehyde at room temperature for 8 min. After washing with PBS, the cells were 127 permeabilised with 0.5% v/v Triton X-100 on ice for 5 min, and rinsed with PBS. Hybridisation 128 was carried out at 42°C in a solution containing 2X saline sodium citrate buffer (SSC), 25% v/v 129 formamide, 1 mg/mL of tRNA, 10% w/v dextran sulfate, and 50 µg/mL oligo-dT probe labelled 130
with Alexa 488 at the 3' end. After hybridisation, the cells were washed twice for 15 min in 2X 131 SSC, and once with 0.5X SSC at 42°C, and then fixed with 4% w/v paraformaldehyde at room 132 temperature for 8 min. After three washes in PBS, the images were acquired using an LSM710 133 Marseille, France) as described by the manufacturer. The sequence of both plasmids have been 140 previously described in detail [19] . The cells were subsequently treated with control siRNA and 141 TF siRNA (Qiagen Inc., Milan, Italy) for 48 h. After silencing, the cells were lysed, and equal 142 amounts of proteins for each condition were assayed for luciferase and β-galactosidase activity 143 using the Dual-Light ® Assay System (Applied Biosystems, Foster City, CA, USA) according to 144 the manufacturer's instructions. The assay data are expressed as the relative ratio of luciferase 145 and β-galactosidase activity. 146
147
Nucleosome immunoassay 148
The histone-complexed DNA fragments (mono-and oligonucleosomes) were quantified using a 149 one-step sandwich immunoassay (Roche Diagnostics, Mannheim, Germany), according to the 150 manufacturer's instructions. The data are expressed as absorbance/mg of cell proteins as 151 determined by the Bradford protein assay. 152
153
Western blotting 154
Cell monolayers were harvested in Laemmli buffer containing 1 mmol/L PMSF, 10 μg/mL aprotinin 155 and 5 mmol/L benzamidine, and equal amounts of proteins were separated on 12% SDS-156 polyacrylamide gel and transferred to nitrocellulose membranes as previously described [20] 
Label-free LC-MS E analysis 225
The cell pellets were dissolved in 25 mmol/L NH 4 HCO 3 containing 0.1% RapiGest (Waters 226 Corporation, Milford, MA, USA) and digested as previously described [23] . The tryptic peptides 227
were separated by means of nanoscale LC using a nanoACQUITY system coupled to a SYNAPT-228 MS, a hybrid Q-TOF mass spectrometer (Waters Corporation, Milford, MA, USA), for 229 qualitative and quantitative multiplexed LC-MS E analysis. The control siRNA-and TF siRNA-230 treated samples (0.5 μg) were mixed with 50 fmol yeast alcohol dehydrogenase (ADH) digest as 231 an internal standard for molar amount estimation [16] , and analysed as previously described [24] . 232
The LC-MS E data were processed and searched using ProteinLynx Global Server (PLGS) v 2.3 233 (Waters Corporation, Milford, MA, USA). Ion detection, data clustering, and the normalisation of 234 the data-independent LC-MS E data have been previously explained in detail [23, 25, 26] . 235
Quantification of differentially expressed proteins identified by LC-MS E was performed by 236 quantifying the peptides identified for each protein using the Expression E algorithm in PLGS v 237 2.3. The regulation likelihood uses the confidence of identification of each peptide as a 238 quantification weighting mechanism, and is specifically designed for independently acquired LC-239 MS data. The overall likelihood of regulation is calculated using the Bayesian statistics-based 240
Quantify algorithm in PLGS v 2.3, and is expressed by the probability of up-regulation (P >1): if 241 this is <0.05 (i.e. between 0 and 0.05), the likelihood of down-regulation is >95%; if it is >0.95 242 (i.e., between 0.95 and 1) the likelihood of up-regulation is >95% [23] . 243 The significance of the regulation level was determined at a 20% fold change, but only proteins 244 identified with at least 2 peptides with similar intensities in the technical replicates (CV<10%) 245
were considered. The entire data set of differentially expressed proteins was further filtered by 246 considering only the identifications from data with identified peptides that replicated at least two 247 out of three technical instrument replicates and in two out of three biological replicates. 248 249
2-dimensional electrophoresis (2-DE) and protein identification 250
The cell pellets were dissolved in urea buffer (8 mol/L urea, 2 mol/L thiourea, 4% CHAPS, 0.8% 251 carrier ampholytes, pH 3-10, 20 mmol/L Tris, 55 mmol/L DTT, and bromophenol blue), and 2-252 DE was carried out in accordance with the manufacturer's protocol (Protean IEF cell, Bio-Rad 253
Laboratories, Milan, Italy) as previously described [27] . 2-DE was performed with three 254 independent biological experiments of control and TF-silenced cells, analysing each sample in 255 triplicate. Progenesis SameSpot software (v 4.0, NonLinear Dynamics, Newcastle upon Tyne, 256 UK) was used for gel alignment, spot detection, spot quantification, and normalisation for total 257 spot volume in each gel, and the data were statistically analysed using the incorporated statistical 258 package [27] . Significant between-group differences for each protein were computed using 259
Student's t test, considering a p value of <0.05 as statistically significant with a fold change cutoff 260 of 1.5. The protein spots selected for mass spectrometry analysis by LC-MS E were in-gel digested 261 with trypsin as previously described [28] . 262
263
Data mining 264
Cytoscape (v 2.7) and BiNGO plugin (v 2.3) were used to make gene ontology (GO) assignments 265 and determine the cell component and biological process GO categories that were significantly 266 under-and over-represented, as previously described [23] . Statistical significance was determined 267
by means of hypergeometric analysis followed by Benjamini and Hochberg's false discovery rate 268 correction (p<0.001) [29] . 269 270
Statistical analysis 271
The data are expressed as mean values ± SEM. The control and treated groups were statistically 272 compared using Student's t-test or ANOVA for repeated measures followed by Tukey's test To analyse the effect of TF on the cardiomyocytic proteome further, we quantitatively compared 289 the proteome of control and TF-silenced cells using a label-free LC-MS E analysis of three 290 independent biological replicates analysed in triplicate. Quality controls of the analysis showed a 291 high mass precision, a retention time CV of <1%, and an intensity CV of <4.5%, which allowed 292 an accurate comparison of the 370 proteins present in at least two out of three technical and 293 biological replicates. The molecular weights, pI, PLGS scores, the mean number of unique 294 identified peptides, sequence coverage, precursor RMS mass errors, and product RMS mass 295 errors are reported in Supplementary Table 1 in [30] . 296
After auto-normalisation, the intensities of accurate mass-retention time component clusters from 297 control and TF-silenced cells were compared using PLGS v 2.3, as described in the Material and 298
Methods section, thus providing a table of the relative fold change in the level of each identified 299
protein. 300
There were 33 non-redundant proteins that were differentially expressed under the two 301 experimental conditions ( Figure 2A ); five were identified only in the control cell proteome, five 302 only in the TF-silenced cells, and 23 in both (nine down-regulated and 14 up-regulated in the TF-303 silenced cells). 304 Table 1 shows the proteins significantly up-or down-regulated in the control and TF-silenced 305 cells, their scores, fold changes (expressed as log(e) of the ratio between the control and TF-306 silenced cells), standard deviations, probabilities, and biological variations. 307
The Biological Networks Gene Ontology (BiNGO) plugin was employed to search for the GO 308 terms statistically over-represented among the differentially expressed proteins. [29] As shown in 309
Supplementary Figure 1A , among the proteins that were down-regulated after TF-silencing or 310
were unique in the control cells, the most over-represented GO terms in the biological process 311 category were mRNA metabolic process and RNA splicing (for additional details see also 312
Supplementary Table 2 3A-B) revealed a statistically significant decrease in the expression of the heterogeneous nuclear 323 ribonucleoprotein K protein, hnRNP K ( Figure 3C) , and a significant increase in the expression 324 of the pro-apototic serine protease HtrA2 ( Figure 3D ), both of which were confirmed by means 325 of immunoblotting ( Figure 3E-F showed that large populations of mRNA species were distributed in the cytoplasm of the control 334 cells, whereas, after cell treatment with TF siRNA, a lower cytoplasmic RNA signal was 335 observed (Figure 4) . 336
We also investigated whether TF silencing affects the distribution of splicing factors such as 337 SRSF2, which is known to be organised in a specific "speckled" distribution pattern in the 338 nucleus. The sub-nuclear organisation of SRSF2-containing speckles was also greatly affected by 339 TF silencing, with an increase in both size and content as measured by immunofluorescence 340 ( Figure 5) . A similar effect was observed in cells in which SF3a (another U2 snRNP component) 341 has been knocked down [32] , or in cells treated with oligonucleotides that inhibit pre-mRNA 342 splicing [33] . 343 344 Effects of TF silencing on pre-mRNA splicing activity 345
In order to examine whether TF plays a role in pre-mRNA splicing in vivo, we used the dual-346 reporter system described by Nasim et al. [19] . The reporter construct (pTN24) contains genes 347 encoding β-galactosidase and luciferase proteins. The assay was constructed in such that in the 348 absence of splicing, it gives rise to β-galactosidase, whereas an efficient splicing reaction 349 generates the fusion of β-galactosidase and luciferase ( Figure 6A ). The splicing efficiency was 350 therefore measured as a relative ratio of luciferase and β-galactosidase activities. TF silencing 351 significantly decreased splicing activity ( Figure 6B ). The co-transfection of pTN24 and pTra2-α, 352
an established splicing activator [19] , increased the luciferase/β-galactosidase ratio 1.6±0. 
TF silencing decreases cardiomyocytic cell viability by influencing the regulators of apoptosis 359
The levels of the phosphorylated forms of Akt and Erk1/2 were examined in order to investigate 360 which of the pathways that ultimately lead to cell apoptosis is affected by TF silencing. The level 361 of phosphorylated Akt was lower in the TF-silenced cells than in the control cells ( Figure 7A) , 362 whereas Erk1/2 levels were not affected (data not shown). Interestingly, Akt inhibition by LY 363 294002 up-regulated the pro-apoptotic serine protease HtrA2, and concomitantly reduced cell 364 growth ( Figure 7B and 7C) . 365
Finally, semi-quantitative RT-PCR revealed an increase in the mRNA of the pro-apoptotic Bcl-x S 366 isoform over the anti-apoptotic Bcl-x L transcripts following TF silencing in human MDA cells 367 which, unlike murine cells, express detectable levels of Bcl-x S [34] (Figure 7D ). The anti-368 apoptotic Survivin and its splice variant, Survivin-DEx-3 were both downregulated in TF-369 silenced cells ( Figure 7E ). The splice variant Survivin-2B, which shows a markedly reduced anti-370 apoptotic potential, was not detectable in our experimental conditions. TNF-related apoptosis 371 inducing ligand (TRAIL), detectable only as regularly spliced TRAILα, was not affected by TF-372 silencing ( Figure 7F) . 373
374
DISCUSSIONS 375
Our proteomic analysis revealed for the first time that TF silencing affects various proteins 376 belonging to the spliceosomal complex [35] and, by modulating spliceosome proteins, inhibits 377 splicing activity, as assessed by means of a dual-reporter mRNA splicing assay, and changes the 378 normal speckled pattern of SRSF2 together with a decreased poly(A) RNA signal in the 379 cytoplasm. The impaired splicing efficiency due to TF silencing was accompanied by a loss of 380 cell survival, which was likely attributable to a decreased level of phosphorylated Akt, an 381 increase in the Bcl-x S spliced isoform, a decrease of the anti-apoptotic wild-type Survivin and 382 Survivin DEx-3 isoforms, and the induction of pro-apoptotic HtrA2 expression. Our results 383 further confirm and extend previous findings by Boltzen et al. [13] showing that TF 384 overexpression protects cardiomyocytes from apoptosis induced by TNF-α by activation of Akt 385 and up-regulation of anti-apoptotic Bcl-x L . 386
The dysregulation of splicing machinery caused by TF silencing is due to alterations in the 387 expression of RNA helicases and splicing factors such as members of the hnRNP family. 388
We found that the expression of DEAD box UAP56 helicase was down-regulated in TF-silenced 389 cells. UAP56 is an important factor for spliceosome assembly, mRNA export and translation, and 390 it plays an important role in cell growth and proliferation [36] [37] [38] . DDX39, a paralogue of 391 UAP56 that is expressed in a growth-regulated manner [39, 40] , was also down-regulated after 392 TF silencing. Another member of the helicase family that was significantly down-regulated by 393 the silencing of TF was DEAD box RNA helicases p72 (DDX17), which plays important roles in 394 multiple cell processes, including transcription, processing of miRNAs and pre-mRNAs and 395 alternative splicing [41] . 396
Five members of the hnRNP family were down-regulated by TF silencing: hnRNP C, A1, D0, L, 397 and K. HnRNP proteins are among the most abundant nuclear proteins (rivalling histones), 398 participate in pre-mRNA processing activities such as splicing and are important determinants of 399 mRNA export, localisation, translation and stability [42] . Given their central role in regulating 400 gene expression, it is not surprising that hnRNPs have been linked to numerous diseases [43] [44] , 401 ranging from cancer to neurodegenerative diseases [45, 46] . 402 Interestingly, hnRNP A1, which was significantly down-regulated in TF-silenced cells, plays a 403 key role in the regulation of cell survival, promoting telomere length extension [47, 48] autophagolysosomal degradation of hnRNP A1 induced by miR-18a lead to cell apoptosis [49] . 406
One new finding is that TF silencing profoundly down-regulated the expression of matrin 3, a 407 highly conserved inner nuclear matrix protein which, through a direct interaction with hnRNP 408 proteins and with the DNA and RNA helicase DHX9, might control RNA metabolism and 409 stabilisation [50] . 410
The proteomic analysis of TF-silenced cells also revealed that other spliceosome proteins were 411 also significantly down-regulated, including SF3b (SAP130) and PTB. It is interesting to note 412 that two natural products, pladienolide B and spliceostatin A, targeting the SF3b subunit of the 413 spliceosome [51] , provoke the accumulation of incompletely processed pre-mRNA, inhibit cell 414 growth [52] and alter the size and number of snRNP-enriched nuclear speckles [32] , similarly to 415 the effects observed by Tanackovic et al., when specific splicing factors are inactivated [53] . 416 PTB binds to uridine-rich sequences and regulates alternative splicing of a variety of pre-mRNAs 417 [54] , acting as a general repressor of exon inclusion. For example, PTB, binding to an exonic 418 splicing silencer, promotes Fas exon 6 skipping and generates a soluble isoform that prevents 419 apoptosis [55] . The finding that TF silencing down-regulates PTB protein level suggests that this 420 splicing modulator is no longer operating. 421 TF silencing also increased the expression of the spliced isoform of the pro-apoptotic Bcl-x S . 422 This is in line with the finding of Boltzen et al., who showed that Bcl-x L is an important factor 423 mediating anti-apoptotic effects in HL-1 cells stably transfected with TF [13] . Bcl-X is closely 424 related to Bcl-2 and exists in several isoforms generated by alternative splicing [56] . The large 425 isoform, Bcl-x L , protects cells against apoptosis, whereas the short isoform Bcl-x S , antagonises 426 the inhibition of cell death by interacting with Bcl-x L and Bcl-2 [56] . It is worth noting that 427 alternative splicing can be regulated by hnRNP proteins binding exonic splicing silencer 428 elements, thus excluding exons from mature mRNA. One study has found that hnRNP K may 429 play a prominent role in alternative splicing control because nearly half of 56 alternative splicing 430 events in apoptotic genes were affected upon hnRNP K depletion, either enhancing or 431 suppressing exon inclusion [57] . In support of our finding, it has been shown that hnRNP K 432 represses the production of the pro-apoptotic Bcl-x S spliced isoform, whereas its down-regulation 433 enhances the splicing of Bcl-x L to Bcl-x S [58] . 434 We also found that the anti-apoptotic Survivin and its splice variant, Survivin-DEx-3, were both 435 down-regulated by TF silencing. Survivin is a member of the inhibitor of apoptosis protein (IAP) 436 family and plays an important role in inhibiting cell apoptosis [59] . In addition to wild-type 437 Survivin, different isoforms characterised by distinct localisation and functions have been 438 identified. For example, Survivin 2B has a pro-apoptotic function, whereas the nuclear Survivin 439 DEx-3 isoform has typically been shown to prevent apoptosis [21] . Our finding is in line with 440 previous results showing that TF-FVIIa-FXa complex prevents apoptosis by a thrombin-441 independent pathway mediated in part by an increase in cell Survivin levels [60] . 442
Although our analysis is limited to few candidates, the effect of TF silencing on apoptosis-related 443 genes does not appear to be widespread because, for example, the TRAIL gene is not affected in 444 TF-silenced cells. TRAIL-α is a member of the TNF family [61] which induces programmed cell 445 death in a wide range of neoplastic cells. 446
The inability to detect, in our experimental system, the pro-apoptotic splice variant of Survivin, 447 Survivin 2B, and the two alternative TRAIL-splice variants, TRAIL-β and TRAIL-γ, which are 448 characterised by the loss of their pro-apoptotic properties [22] , does not allow us to establish a 449 clear relationship between TF-mediated deregulation of splicing factors and these proteins 450 involved in the apoptotic process. 451
As stated above, in addition to being the main initiator of the blood coagulation cascade, TF is 452 also a true signalling receptor that acts by means of various mechanisms, including the activation 453 of protease-activated receptors 1 and 2, via the TF cytoplasmic domain and the transactivation of 454 receptor tyrosine kinases. The activation of signalling cascades such as the mitogen-activated 455 protein kinase and phosphoinositide 3-kinase (PI3K)/Akt pathways relates TF to a multitude of 456 cell functions, such as cell survival, migration, and proliferation [62, 63] . 457
It is worth noting that TF silencing significantly reduced phosphorylated Akt levels, whereas the 458 levels of phosphorylated Erk1/2 were unaffected. Furthermore, Akt inhibition led to the induction 459 of apoptosis because Akt is a serine/threonine kinase that, once activated by phosphorylation, 460 plays an important role in regulating a number of cell processes that deliver an anti-apoptotic 461 signal. Supporting the association between TF level and cell survival, cardiomyocytes stably 462 transfected with TF show less TNFα-induced apoptosis and a higher degree of activation of the 463 Akt pathway [13] . Moreover, anti-apoptotic Bcl-x L expression was increased in HL-1 cells 464 overexpressing TF, thus underlining the positive association between TF, the Akt pathway and 465
anti-apoptotic Bcl-x L . Interestingly, PI3K/Akt signaling pathway has been implicated to play an 466 important role in the regulation of Survivin [64] . 467
The nature of the interaction between signalling pathway and splicing machinery in TF-silenced 468 cells was not elucidated in this study, but we can hypothesise that splicing factors may represent 469 targets of the signaling molecules. A wide variety of interactions have been described between 470 components of the RNA processing machinery and traditional signalling molecules: for example, 471 hnRNP K protein contains multiple modules that bind kinases while recruiting chromatin, 472 transcription, splicing and translation factors [65] . We focused our analysis to kinases such as the 473 mitogen-activated protein kinase and PI3-kinase/Akt pathways because they are related TF 474 signalling, and we have not analysed the full spectrum of kinases and phosphatases (reviewed in 475 [66] ) involved in the post-traslational modifications of the spliceosomal components and 476 accessory splicing factors which significantly contribute to their activity. Regulation of splicing 477 factors by Akt is not heretical [67] ; activated Akt has been involved in directly modulating 478 serine/arginine-rich proteins (SR proteins) [68] ; more recently, hnRNP L has been recently 479 identified as a direct substrate of Akt, thus influencing the alternative splicing of caspase-9 [69] , 480 and down-regulation of splicing factors has been also observed in U373 glioma cells after Akt 481 silencing [70] . Furthermore, SR-specific protein kinases (SRPKs) are also directly regulated by 482 Akt [71] ; lastly, a phosphoproteomic screen of Akt isoforms identified 25 RNA processing 483 proteins including splicing factors as Akt isoform-dependent targets [72] . 484
Our data also reveal for the first time that TF silencing up-regulates HtrA2 expression, and that 485 blocking Akt signaling by means of the PI3K inhibitor LY294002 modulates HtrA2 in a similar 486 manner, thus providing a further mechanism by which TF promotes cell survival through Akt. 487
The serine protease HtrA2 leads to programmed cell death in both a caspase-dependent and 488 caspase-independent manner. Its function closely relates to its protease activity, which is required 489 for the cleavage of its substrates. However, the regulation of HtrA2 by a signalling molecule has 490 not been previously documented. Yang et al. have 
demonstrated that the ectopic expression of 491
HtrA2 considerably induces programmed cell death, whereas apoptosis is largely reduced by 492 constitutively active Akt [73] . 493 We recognise some limitations in our study. One limitation is the fact that we could not 494 discriminate the relative contribution of full-length and alternatively spliced TF, which are both 495 expressed in the cardiomyocytic cells although to different extents (full-length TF is the main 496 isoform and accounts for 85±6% of expressed TF) (Supplementary Figure 2) and, although they 497 have functionally different features, appear to be involved in similar biological processes [62] . 498
We evidenced a reorganization of SRSF2 in TF-silenced cells in which "speckles became larger, 499 rounded and decreased in number with a concurrent increase in their fluorescent intensity" 500 attributable to the "return of splicing factor to theirs site of storage and/or assembly, until splicing 501 is resumed", similarly to what observed by O'Keefe et al. [33] . However, a precise picture of the 502 SR proteins involved in this phenomenon has not been depicted as the antibody used does not 503 discriminate between SRSF2 and SRSF2-related non-snRNP factor SF2/ASF. As a detailed 504 analysis of the phosphorylation state of SR proteins has not been addressed, we can only 505 speculate that, similarly to what observed by Sacco-Bubulya P. et al [74] , a reduced 506 phosphorylation causes retention of SR proteins in nuclear spleckles. 507
Finally, the decreased level of poly(A) signal in the cytoplasm of TF-silenced cells does not 508 necessarily imply that poly(A) transcripts are improperly spliced and retained in the nucleus, as 509 we could not see any visible increase of the nuclear signal. Thus the effect of TF silencing on 510 mRNA biogenesis or on the mRNA export machinery [75] deserves further detailed 511 investigations, however, it is not unlikely that splicing factors might alter the polyadenylation 512 process as observed for PTB (reviewed in [76] ) 513 Nevertheless, the possibility that altered TF expression has an impact on overall splicing activity 514 may help to explain its role in those diseases in which both TF and splicing activity are down-515 regulated, and opens new avenues for the investigations of splicing regulation by TF. 516
Although cardiomyopathies are only beginning to be explored in terms of splicing machinery, 517 recent evidence suggests that RNA splicing is less efficient in humans with heart failure. Splicing 518 changes have also been observed in hypertrophic myocardium with preserved systolic function, 519 which suggests that they may occur before the onset of overt heart failure [77, 78] . 520
It is worth noting that TF is down-regulated in the myocardium of patients with dilated 521 cardiomyopathy [9] , and that the deletion of the TF gene in mouse cardiomyocytes 522 (TF flox/flox/ MLC2v-Cre) leads to significantly increased fibrosis [79] . 523
The mechanisms underlying these phenomena have not been previously investigated, but our 524 findings suggest that TF plays a role in controlling splicing machinery, although further studies 525 are required to determine whether this mechanism is operative in cells other than cardiomyocytes. 526 527
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